Women's Health: Trends and Opportunities in the U.S. Osteoporosis Management Market

Osteoporosis is a common metabolic bone disease that is characterized by the loss of bone mineral density (BMD). The disease contributes to weakened bone tissue and a propensity for fractures, and is one of the major contributors to orthopedic injuries, especially in women. Although the disease is not restricted to women, and many factors contribute to the cause of osteoporosis, the most significant factor for women is menopause. An increase in this demographic group will play a key role in the continual demand for osteoporosis management products during the forecast period covered by this report. This report provides analyses of products, markets, and competitors in the United States (U.S.) market for osteoporosis management products. This market, as covered by the scope of this report, includes products that are used to diagnose and treat osteoporosis including bone densitometry systems, bone remodeling biochemical marker tests, and pharmaceutical treatments such as estrogen/hormone therapy (HT) and osteoporosis drugs.